Who is sponsoring NCT04266158?

NCT04266158 is sponsored by Ohio State University.

What drugs are being tested in NCT04266158?

Interventions in NCT04266158: Myoelectric UE Device-UE Orthosis-No Device.

What condition does NCT04266158 study?

NCT04266158 studies Paresis, Stroke.

Is NCT04266158 still recruiting?

NCT04266158 is currently terminated. Last updated 11 April 2022.

Are results published for NCT04266158?

Yes — primary outcome results have been posted to ClinicalTrials.gov. See the outcomes section above for details.

Last reviewed 2022-04-11 · How we verify

NCT04266158: FAME

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

FAME: Functional Assessment of a Myoelectric Orthosis Hand Orthoses

Terminated NA Results posted Last updated 11 April 2022

What this trial tests

NA trial testing Myoelectric UE Device-UE Orthosis-No Device in Paresis in 28 participants. Terminated before completion.

Timeline

1 October 2017

Primary endpoint
18 September 2018

18 September 2018

Quick facts

Lead sponsor	Ohio State University
Phase	NA
Status	Terminated
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	28
Start date	1 October 2017
Primary completion	18 September 2018
Estimated completion	18 September 2018
Sites	1 location across United States

Drugs / interventions tested

Myoelectric UE Device-UE Orthosis-No Device

Conditions studied

Paresis — all drugs for Paresis →
Stroke — all drugs for Stroke →

Sponsor

Ohio State University

Who can join

Adults 18 to 85, any sex, with Paresis or Stroke. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The primary study objective is to compare post-stroke upper extremity (UE) movement while wearing a brace called the MyoPro 2 Motion G versus UE movement while wearing a resting splint and no device in stroke survivors with moderate UE dysfunction. During the study, subjects will undergo general training in the operation of the EMG-controlled orthosis and the comparison orthosis, and then guided through a series of standard clinical outcome measures. These outcome measures will allow the researchers to directly compare the relative benefit of the MyoPro 2 Motion G with a resting hand splint and no device in reducing UE impairment and increasing UE dexterity and functional task performance.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Paresis

Currently open trials in the same condition.

NCT07288385 — Investigating the Feasibility of Combining Virtual Reality and Bilateral Transcranial Direct Stimulation to Improve Uppe · NA · recruiting
NCT06282406 — Pupil-Indexed Noninvasive Neuromodulation · NA · recruiting
NCT04755699 — Chronic Transcutaneous Stimulation to Promote Motor Function and Recovery in Individuals With Paralysis or Paresis · EARLY_PHASE1 · recruiting

Other Ohio State University trials

Trials by the same sponsor.

NCT06542458 — Under-Represented Communities Diagnosed With SCD or MCI Through Tele-Cog · not yet recruiting
NCT07217548 — Solving Stigma Through POV Simulation: Enhancing Pharmacist Empathy-based Practices With Sickle Cell Disease Patients · NA · enrolling by invitation
NCT07215221 — Implementation of TBI-RECOVER in Substance Use Treatment · NA · not yet recruiting
NCT07278427 — Reducing Parental Substance Use and Enhancing Family Resilience Among Rural Families Through Ohio START · recruiting
NCT07490444 — Metric-Optimized Spectacle Prescriptions for Children With Down Syndrome · Phase 2 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04266158 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Ohio State University
Last refreshed: 11 April 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04266158.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing